Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 954863, 11 pages
http://dx.doi.org/10.1155/2014/954863
Review Article

Aspirin Resistance and Promoting Blood Circulation and Removing Blood Stasis: Current Situation and Prospectives

Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange 5, Xicheng District, Beijing 100053, China

Received 6 October 2013; Accepted 30 December 2013; Published 18 February 2014

Academic Editor: Tabinda Ashfaq

Copyright © 2014 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Tseeng and R. Arora, “Reviews: aspirin resistance: biological and clinical implications,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 13, no. 1, pp. 5–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Rafferty, M. R. Walters, and J. Dawson, “Anti-platelet therapy and aspirin resistance—clinically and chemically relevant?” Current Medicinal Chemistry, vol. 17, no. 36, pp. 4578–4586, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Kottke, “The ultimate solution to the problem of aspirin resistance,” Journal of the American College of Cardiology, vol. 52, no. 15, p. 1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Gum, K. Kottke-Marchant, P. A. Welsh, J. White, and E. J. Topol, “A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease,” Journal of the American College of Cardiology, vol. 41, no. 6, pp. 961–965, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Cattaneo, “Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 1980–1987, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Antithrombotic Trialists Collaboration, “Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients,” British Medical Journal, vol. 324, no. 7330, p. 141, 2002. View at Google Scholar
  7. C. R. Conti, “Is aspirin resistance a risk factor?” Clinical Cardiology, vol. 28, no. 4, pp. 163–164, 2005. View at Google Scholar · View at Scopus
  8. T. L. Pinto Slottow, L. Bonello, R. Gavini et al., “Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis,” The American Journal of Cardiology, vol. 104, no. 4, pp. 525–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Mattiello, R. Guerriero, L. V. Lotti et al., “Aspirin extrusion from human platelets through multidrug resistance protein-4-Mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting,” Journal of the American College of Cardiology, vol. 58, no. 7, pp. 752–761, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Musallam, K. Charafeddine, A. Bitar et al., “Resistance to aspirin and clopidogrel therapy,” International Journal of Laboratory Hematology, vol. 33, no. 1, pp. 1–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. FitzGerald and M. Pirmohamed, “Aspirin resistance: effect of clinical, biochemical and genetic factors,” Pharmacology and Therapeutics, vol. 130, no. 2, pp. 213–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Tousoulis, G. Siasos, and C. Stefanadis, “Aspirin resistance: what the cardiologist needs to know?” International Journal of Cardiology, vol. 132, no. 2, pp. 153–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Grinstein and C. P. Cannon, “Aspirin resistance: current status and role of tailored therapy,” Clinical Cardiology, vol. 35, no. 11, pp. 673–680, 2012. View at Google Scholar
  14. L. C. Heistein, W. A. Scott, T. M. Zellers et al., “Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms,” Pediatric Cardiology, vol. 29, no. 2, pp. 285–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Bradbury, “Aspirin resistance may increase death risk in some patients with heart disease,” The Lancet, vol. 359, no. 9312, p. 1128, 2002. View at Google Scholar · View at Scopus
  16. V. S. Thomson, B. John, P. George, G. Joseph, and J. Jose, “Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events,” Journal of Postgraduate Medicine, vol. 55, no. 4, pp. 252–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Harrison, “Platelet function analysis,” Blood Reviews, vol. 19, no. 2, pp. 111–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Y. Gasparyan, T. Watson, and G. Y. H. Lip, “The role of aspirin in cardiovascular prevention. Implications of aspirin resistance,” Journal of the American College of Cardiology, vol. 51, no. 19, pp. 1829–1843, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Xu and K.-J. Chen, “Making evidence-based decisions in the clinical practice of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 483–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wang and X. J. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar
  21. M. Y. Liu and K. J. Chen, “Convergence: the tradition and the modern,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 164–165, 2010. View at Google Scholar
  22. K. J. Chen, H. Xu, M. S. Lee et al., “The potential benefit of complementary/alternative medicine in cardiovascular diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 125029, 1 pages, 2012. View at Publisher · View at Google Scholar
  23. H. Xu and K. J. Chen, “Complementary and alternative medicine: is it possible to be mainstream?” Chinese Journal of Integrative Medicine, vol. 18, pp. 403–404, 2012. View at Google Scholar
  24. K.-J. Chen, “Clinical service of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 14, no. 3, pp. 163–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-J. Chen, “Where are we going?” Chinese Journal of Integrative Medicine, vol. 16, no. 2, pp. 100–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Keji and X. Hao, “The integration of traditional Chinese medicine and Western medicine,” European Review, vol. 11, no. 2, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-J. Chen and L.-Z. Li, “Study of traditional Chinese medicine—which is after all the right way?” Chinese Journal of Integrative Medicine, vol. 11, no. 4, pp. 241–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Xu and K. Chen, “Integrative medicine: the experience from China,” Journal of Alternative and Complementary Medicine, vol. 14, no. 1, pp. 3–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Q.-H. Shang, H. Xu, X.-Y. Lu, C. Wen, D.-Z. Shi, and K.-J. Chen, “A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients,” Chinese Journal of Integrative Medicine, vol. 17, no. 9, pp. 669–674, 2011. View at Google Scholar · View at Scopus
  30. Z. Y. Gao, H. Xu, B. Y. Liu et al., “Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine,” Journal of Ethnopharmacology, vol. 141, no. 2, pp. 578–583, 2012. View at Publisher · View at Google Scholar
  31. K.-J. Chen, D.-Z. Shi, H. Xu et al., “XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China,” Chinese Medical Journal, vol. 119, no. 1, pp. 6–13, 2006. View at Google Scholar · View at Scopus
  32. Q. Shang, H. Xu, and L. Huang, “Tanshinone IIA: a promising natural cardioprotective agent,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 716459, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Matsumoto, T. Kojima, K. Ogawa et al., “A proteomic approach for the diagnosis of 'Oketsu' (blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 463–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Terasawa, K. Toriizuka, H. Tosa et al., “Rheologicalstudieson“ oketsu” syndrome.The blood viscosity and diagnostic criteria,” Journal of the Medical and Pharmaceutical Society For WAKAN-YAKU, vol. 3, no. 4, pp. 98–104, 1986. View at Google Scholar
  35. E. Nurtjahja-Tjendraputra, A. J. Ammit, B. D. Roufogalis, V. H. Tran, and C. C. Duke, “Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger,” Thrombosis Research, vol. 111, no. 4-5, pp. 259–265, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Li and H. Xu, “The occurrence of cardiovascular events of coronary heart disease in patients and study on Chinese medicine syndrome distribution laws,” Chinese Journal of Integrative Medicine, vol. 32, pp. 603–606, 2012. View at Google Scholar
  37. J. Wang and X. J. Xiong, “Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 697237, 7 pages, 2012. View at Publisher · View at Google Scholar
  38. J. Wang, P. Q. Wang, and X. J. Xiong, “Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine,” Internal Medicine, vol. 2, no. 3, Article ID 100013, 2012. View at Google Scholar
  39. K. J. Chen, “Progress of research on blood stasis syndrome in China and abroad,” Clinical Focus, vol. 2, no. 1, pp. 16–18, 1987. View at Google Scholar
  40. Z. Q. Yu, S. Xie, J. Li et al., “Effects of three traditional Chinese drug constituents on the activity of aspirin esterase in human plasma,” Zhong Guo Yi Yuan Yao Xue Za Zhi, vol. 30, no. 19, pp. 1663–1666, 2010. View at Google Scholar
  41. G. Liu and J. H. Guo, “Aspirin resistance and its clinical strategies,” Yi Xue Yu Zhe Xue, vol. 29, no. 8, pp. 13–17, 2008. View at Google Scholar
  42. J. W. Zhao, “Aspirin resistance and blood stasis,” Shi Yong Zhong Yi Nei Ke Za Zhi, vol. 26, no. 5, pp. 65–67, 2012. View at Google Scholar
  43. K. J. Chen, M. Xue, and H. J. Yin, “The relationship between platelet activation and coronary heart disease and blood-stasis syndrome,” Chinese Journal of Integrative Medicine, vol. 14, no. 4, pp. 266–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Xue, K.-J. Chen, and H.-J. Yin, “Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome,” Chinese Journal of Integrative Medicine, vol. 14, no. 4, pp. 267–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. S. Zhu, “Aspirin resistance and traditional chinese medicine,” Liao Ning Zhong Yi Yao Da Xue Xue Bao, vol. 12, no. 6, pp. 257–259, 2010. View at Google Scholar
  46. K.-J. Chen, “Exploration on the possibility of reducing cardiovascular risk by treatment with Chinese medicine recipes for promoting blood-circulation and relieving blood-stasis,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 5, p. 389, 2008. View at Google Scholar · View at Scopus
  47. J. P. Lin and X. D. Fu, “The research progress in aspirin resistance with traditional chinese herbs as synergistic or alternative treatments,” Shang Hai Yi Yao, vol. 32, no. 8, pp. 379–382, 2011. View at Google Scholar
  48. Z. Q. Chai, L. Wei, and J. Ding, “Interference of Compound Cardiotonic Pill with aspirin resistance: a clinical trial,” Shi Yong Yi Xue Za Zhi, vol. 25, no. 4, pp. 387–389, 2008. View at Google Scholar
  49. N. Peng, Q. S. Liu, and L. Liang, “Study on TCM syndrome distribution patterns of aspirin resistance in coronary atherosclerosis and influence of huoxue capsule,” Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, vol. 9, no. 3, pp. 257–259, 2011. View at Google Scholar
  50. J. Yang, Y. H. Cheng, and Y. Sun, “Effect of Naoxintong on aspirin resistance in patients with coronary heart disease,” Zhong Guo Xian Dai Yao Wu Ying Yong, vol. 5, no. 17, pp. 80–81, 2011. View at Google Scholar
  51. C. H. Yin, D. P. Bi, and M. Du, “Effect of tongxinluo capsule on platelet aggregation function in patients with aspirin resistance,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 30, no. 4, pp. 380–382, 2010. View at Google Scholar
  52. S. J. Song, X. Z. Zhao, Y. Wang, and X. D. Zhou, “Effects of tongxinluo capsule on C-reactive protein and thromboxan B2 in patients with acute coronary syndrome companied with aspirin resistance,” Shan Dong Yi Yao, vol. 48, no. 31, pp. 13–15, 2008. View at Google Scholar
  53. Y. Liu, L. P. Sun, and H. Y. Yang, “Evaluation of curative effect of cardiovascular adverse events and laboratory indexes interventing patients with aspirin resistance by Xin nao shu tong capsule combined with aspirin,” Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, vol. 9, no. 5, pp. 518–519, 2011. View at Google Scholar
  54. T. H. Wu, “Clinical observation on platelet aggregation of patients with aspirin resistance by xuefu zhuyu decoction,” Shi Zhen Guo Ji Yi Yao, vol. 23, no. 6, pp. 1586–1587, 2012. View at Google Scholar
  55. G. Luo, H. Chen, and X. Bai, “Clinical experiment intervention of zhilong huoxue tongyu capsule on aspirin resistance and its mechanism,” Lu Zhou Yi Xue Yuan Xue Bao, vol. 35, no. 1, pp. 50–51, 2012. View at Google Scholar
  56. W. J. Xiu, “DAXXK intervention clinical trials of aspirin resistance and its mechanism,” Zhong Guo Yao Ye, vol. 21, no. 15, pp. 26–28, 2012. View at Google Scholar
  57. H. J. Yang, H. P. Huang, and H. F. Xu, “50 Clinical Trials of Aspirin Resistance by combination of aspirin and Ginkgo biloba extract,” Yi Yao Dao Bao, vol. 30, no. 5, pp. 614–615, 2011. View at Google Scholar
  58. H. Xu and K.-J. Chen, “Difficulties and countermeasures in research for prevention and treatment of coronary heart disease by integrative Chinese and Western medicine,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 27, no. 7, pp. 647–649, 2007. View at Google Scholar · View at Scopus
  59. M. Xue, H. J. Yin, K. J. Chen et al., “Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis inflammatory reaction and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome,” Chinese Journal of Integrative Medicine, vol. 19, pp. 42–47, 2013. View at Google Scholar
  60. Y. Lei, Q. Gao, and K.-J. Chen, “Effects of extracts from panax notoginseng and panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro,” Chinese Journal of Integrative Medicine, vol. 14, no. 1, pp. 37–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Y.-R. Jiang, Y. Miao, L. Yang et al., “Effect of chinese herbal drug-containing serum for activating-blood and dispelling-toxin on ox-LDL-induced inflammatory factors' expression in endothelial cells,” Chinese Journal of Integrative Medicine, vol. 18, no. 1, pp. 30–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. K. H. Cho, K. P. Kim, and B. C. Woo, “Relationship between blood stasis syndrome score and cardioankle vascular index in stroke patients,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 696983, 7 pages, 2012. View at Publisher · View at Google Scholar
  63. H. Xu and K.-J. Chen, “Making evidence-based decisions in the clinical practice of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 483–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Wang, B. Feng, X. J. Xiong et al., “Tai Chi for essential hypertension,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 215254, 10 pages, 2013. View at Publisher · View at Google Scholar
  65. J. Wang and X. Xiong, “Control strategy on hypertension in Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 284847, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. J. T. Han and X. J. Xing, “Overview of pharmacological research of leech,” Academic Periodical of Changchun College of Traditional Chinese Medicine, vol. 22, no. 1, p. 89, 2006. View at Google Scholar
  67. Q. Y. Chen, M. W. Huang, and S. F. Ke, “Effect of Leech Capsule on stability of carotid plaque and expression of platelet membrane glycoprotein,” Chinese Journal of Traditional Chinese Medicine, vol. 24, no. 12, pp. 25–26, 2009. View at Google Scholar
  68. N. Li, X. Zhao, and W. G. Zhang, “Inhibitory effect to platelet activation of Hirudo micropowder observed in patients with unstable angina,” Medical & Pharmaceutical World, vol. 11, no. 4, pp. 1643–1645, 2009. View at Google Scholar
  69. G. L. Zheng, Y. S. Wu, and W. G. Zhang, “Effect of vWF, GMP-140 of ultra-fine particle of leeches in treating acute brain infarction disease,” Journal of Shandong University, vol. 44, no. 9, pp. 960–963, 2006. View at Google Scholar
  70. Y. Zhang, G.-Z. Han, L. Lü, F. Yu, Q. Lu, and Q.-Y. Dai, “Anti-DIC effect of Hirulog-s, a novel hirudin-derived anticoagulant peptide, in rabbits,” Chinese Journal of New Drugs, vol. 21, no. 6, pp. 611–615, 2012. View at Google Scholar · View at Scopus
  71. Y. J. Wang, H. M. Liu, and J. Li, “Study of semenpersicae on the inhibition of platelet aggregation,” Shanghai Medical & Pharmaceutical Journal, vol. 19, no. 3, pp. 27–28, 1998. View at Google Scholar
  72. Z. B. Wu, D. Wang, and Q. Y. Liu, “Study on the anti-coagulation mechanism of total paeony glycosides,” Journal of Anhui University of Traditional Chinese Medicine, vol. 29, no. 3, pp. 39–42, 2007. View at Google Scholar
  73. X. X. Xu, L. Z. Xia, and J. R. Gao, “Synergistic antithrombotic action between astragalosides and total saponins of paeonia,” Journal of Chinese Medicinal Materials, vol. 25, no. 9, pp. 653–655, 2002. View at Google Scholar
  74. J. Han, H. Y. Liu, and Z. Q. Xiao, “Discussion of Astragalus on the effect of activating blood circulation,” Yunnan Journal of Traditional Chinese Medicine, vol. 29, no. 3, pp. 21–22, 2008. View at Google Scholar
  75. W. G. Sun, H. L. Liao, and Z. S. Huang, “Intervention effect of Chinese herbal medicine on changes of immune system in senile dementia,” Chinese Journal of Integrated Traditional and Western, vol. 21, no. 9, pp. 716–718, 2001. View at Google Scholar · View at Scopus
  76. J. Gao, X. X. Xu, and X. J. Xu, “Research on antithrombotic effect of total saponins of Astragalus,” Chinese Traditional Patent Medicine, vol. 24, no. 2, pp. 116–118, 2002. View at Google Scholar
  77. Y. Xu, P. Q. Gao, and Q. C. Liang, “Experimental study on effect of Astragalus Polysaccharide to the cerebral thrombosis,” Chinese Journal of Hematology, vol. 9, no. 3, pp. 133–136, 1999. View at Google Scholar
  78. Q. Y. Wang, J. L. Li, and Y. Y. Liu, “Effect of Astragalus Injection on the formation of venous thrombosis in rats,” Chinese Traditional Patent Medicine, vol. 25, no. 6, p. 498, 2003. View at Google Scholar
  79. Y. Wu, J. P. Ouyang, and S. Z. Tu, “Effects of Astragalus Polysaccharides on atherosclerosis endothelial cell injury,” Journal of Hubei College of Traditional Chinese Medicine, vol. 4, no. 1, p. 21, 2002. View at Google Scholar
  80. K. Terasawa, “Evidence-based reconstruction of kampo medicine: part ii-the concept of sho,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 2, pp. 119–123, 2004. View at Google Scholar
  81. K. J. Chen, “Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy,” Chinese Journal of Integrative Medicine, vol. 18, no. 12, pp. 891–896, 2012. View at Google Scholar
  82. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” PLoS Medicine, vol. 7, no. 3, Article ID e1000251, 2010. View at Publisher · View at Google Scholar · View at Scopus